BioCentury
ARTICLE | Clinical News

Avastin bevacizumab regulatory update

December 7, 2009 8:00 AM UTC

Ontario's Ministry of Health and Long-Term Care said it renegotiated pricing for Roche's Avastin bevacizumab, which the agency's New Drug Funding Program will now cover for up to 24 cycles, up from 16...